Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Marc LustigDirector | BriaCell TherapeuticsBCTX | Open-market buy | 24/05/14 | 24/05/20 | 902,935 sh | $2.22 | $2,004,515.7 | +55.1% |
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Marc LustigDirector | BriaCell TherapeuticsBCTX | Open-market buy | 24/05/14 | 24/05/20 | 902,935 sh | $2.22 | $2,004,515.7 | +55.1% |